SIRPA and cancer: The formation of complexes with CD47 and SIRPα transmits an antiphagocytic signal to macrophages, and the CD47-SIRPα pathway serves as an innate immune checkpoint to function as a druggable target, which enables cancer cells to escape from phagocytosis mediated by macrophages [296].